GoodRx Holdings, Inc. (GDRX) closed the last trading session at $6, gaining 11.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $7.67 indicates a 27.8% upside potential.The average comprises 15 short-term price targets ranging from a low of $4.50 to a high of $12, with a standard deviation of $2.17. While the lowest estimate indicates a decline of 25% from the current price level ...

During flu season, you want to be on top of your strategy on how to quickly get better if you’re sick.Each month, PYMNTS tracks the most popular mobile apps in the prescription space for the Provider Ranking of Prescription Apps. By observing app use metrics, we score applications to determine the top players.For the sixth consecutive month, GoodRx leads the pack. CVS Caremark, CenterWell Pharmacy and Nimble Rx show the most upward score variation, each gaining three points. Publix Pharmacy loses the most g ...

PixelsEffect Summary I am recommending a buy rating for GoodRx Holdings (NASDAQ:GDRX) stock. I believe the GDRX solution has a very strong value proposition for all the parties in its network, which should continue to support adoption. With more consumers joining the network because of the cost savings, it will attract more PBMs to join the network, which will form a virtuous cycle, allowing GDRX to grow along with more volume routing through its network. Company description GDRX main business is to hel ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today announced its intention to refinance its first lien credit facilities. The Company is seeking to refinance its first lien term loan facility and concurrently amend its revolving credit facility to extend the maturity date. The terms of the proposed refinancing, if any, will be disclosed upon the completion of the transaction, which is expected to o ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock char ...

GoodRx Holdings, Inc. (GDRX) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.Analysts' growing optimism on the earnings prospects of this company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revis ...

GoodRx Holdings, Inc. (GDRX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GDRX's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross."Considered an important signifier for a bullish breakout, a golden cross is a technical chart pattern that's formed when a stock's short-term moving average breaks above a longer-term moving average; the most common crossover involves the 50-day and the ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), the leading destination for prescription savings, today shared a report looking at the company’s impact on social welfare as a result of helping millions of people access affordable medications. “The GoodRx Effect: How GoodRx is Changing the Economics of Healthcare” shows that by saving people money and improving medication adherence, GoodRx positively impacts health outcomes and significantly reduces costs within the healthcare system – includin ...

GoodRx Holdings, Inc. (GDRX) shares rallied 13.3% in the last trading session to close at $6.47. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 0.2% loss over the past four weeks.GoodRx scored a strong price increase, on investors’ optimism driven by the company’s announcement of preliminary financial results for the fourth quarter and fiscal year ended Dec 31, 2023. The company’s fourth quarter revenues are ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today provided preliminary unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Revenue1,2 and Adjusted Revenue1,2 expected to be in the range of $195 million to $197 million Adjusted EBITDA Margin2,3 expected to be in the upper end of previous guidance range provided on November 9, 2023 ...